Evidence map›Paper›PMID 28067630›Full record

ArticleDisease models & mechanisms2017

A novel swine model of ricin-induced acute respiratory distress syndrome.

Shahaf Katalan, Reut Falach, Amir Rosner, Michael Goldvaser, Tal Brosh-Nissimov, Ayana Dvir, Avi Mizrachi, Orr Goren, Barak Cohen, Yoav Gal and 4 more

Open access · goldAbstract read
In one paragraph

Article in Disease models & mechanisms, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Shahaf KatalanDepartment of Pharmacology, Israel Institute for Biological Research, 7410001 Ness-Ziona, Israel shahafk@iibr.gov.il tamars@iibr.gov.il.
Reut FalachDepartment of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, 7410001 Ness-Ziona, Israel.
Amir RosnerVeterinary Center for Preclinical Research, Israel Institute for Biological Research, 7410001 Ness-Ziona, Israel.
Michael GoldvaserDepartment of Organic Chemistry, Israel Institute for Biological Research, 7410001 Ness-Ziona, Israel.
Tal Brosh-NissimovInfectious Disease Unit, Sheba Medical Center, 5262160 Tel-Hashomer, Israel.
Ayana DvirGeneral Intensive Care Unit, Asaf Harofeh Medical Center, 70300 Zerifin, Israel.
Avi MizrachiGeneral Intensive Care Unit, Kaplan Medical Center, 7661041 Rehovot, Israel.
Orr GorenAnesthesia, Pain and Intensive Care Division, Tel-Aviv Medical Center, Tel-Aviv University, 6093000 Tel-Aviv, Israel.
Barak CohenAnesthesia, Pain and Intensive Care Division, Tel-Aviv Medical Center, Tel-Aviv University, 6093000 Tel-Aviv, Israel.
Yoav GalDepartment of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, 7410001 Ness-Ziona, Israel.
Anita SapoznikovDepartment of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, 7410001 Ness-Ziona, Israel.
Sharon EhrlichDepartment of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, 7410001 Ness-Ziona, Israel.
Tamar SaboDepartment of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, 7410001 Ness-Ziona, Israel shahafk@iibr.gov.il tamars@iibr.gov.il.ORCID 0000-0001-8917-3669
Chanoch KronmanDepartment of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, 7410001 Ness-Ziona, Israel.
Israel Institute for Biological Research · ILTel Aviv University · ILAssaf Harofeh Medical Center · ILKaplan Medical Center · ILSheba Medical Center · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pulmonary exposure to the plant toxin ricin leads to respiratory insufficiency and death. To date, in-depth study of acute respiratory distress syndrome (ARDS) following pulmonary exposure to toxins is hampered by the lack of an appropriate animal model. To this end, we established the pig as a large animal model for the comprehensive study of the multifarious clinical manifestations of pulmonary ricinosis. Here, we report for the first time, the monitoring of barometric whole body plethysmography for pulmonary function tests in non-anesthetized ricin-treated pigs. Up to 30 h post-exposure, as a result of progressing hypoxemia and to prevent carbon dioxide retention, animals exhibited a compensatory response of elevation in minute volume, attributed mainly to a large elevation in respiratory rate with minimal response in tidal volume. This response was followed by decompensation, manifested by a decrease in minute volume and severe hypoxemia, refractory to oxygen treatment. Radiological evaluation revealed evidence of early diffuse bilateral pulmonary infiltrates while hemodynamic parameters remained unchanged, excluding cardiac failure as an explanation for respiratory insufficiency. Ricin-intoxicated pigs suffered from increased lung permeability accompanied by cytokine storming. Histological studies revealed lung tissue insults that accumulated over time and led to diffuse alveolar damage. Charting the decline in PaO2/FiO2 ratio in a mechanically ventilated pig confirmed that ricin-induced respiratory damage complies with the accepted diagnostic criteria for ARDS. The establishment of this animal model of pulmonary ricinosis should help in the pursuit of efficient medical countermeasures specifically tailored to deal with the respiratory deficiencies stemming from ricin-induced ARDS.

Indexed as

AnimalsBlood Cell CountBody TemperatureBronchoalveolar Lavage FluidCytokinesDisease Models, AnimalEndothelin-1FemaleHydrogen-Ion ConcentrationInflammation MediatorsLungLung InjuryOxygenPartial PressurePermeabilityPneumoniaCytokinesEndothelin-1Inflammation MediatorsOxygenRicinAnimal modelARDSInflammationLung permeabilityPigRicin

Identifiers

PMID28067630
PMCPMC5312011
OpenAlexW2569247852

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.